Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cell and Tissue-Based Therapy”

171 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 171 results

Testing effectiveness (Phase 2)Ended earlyNCT04310397
What this trial is testing

Dabrafenib, Trametinib, and Spartalizumab for the Treatment of BRAF V600E or V600K Mutation Positive Stage IIIB/C/D Melanoma

Who this might be right for
Pathologic Stage IIIB Cutaneous Melanoma AJCC v8Pathologic Stage IIIC Cutaneous Melanoma AJCC v8Pathologic Stage IIID Cutaneous Melanoma AJCC v8
M.D. Anderson Cancer Center 4
Very early researchStudy completedNCT01434342
What this trial is testing

Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients

Who this might be right for
Lung CancerTobacco Use DisorderBreast Cancer+2 more
Wake Forest University Health Sciences 146
Testing effectiveness (Phase 2)UnknownNCT01857453
What this trial is testing

Interest of a Dose Decrease for Radiotherapy Associated With Chemotherapy for Treatment of Standard Risk Adult Medulloblastomas

Who this might be right for
Medulloblastoma
Central Hospital, Nancy, France 97
Large-scale testing (Phase 3)Study completedNCT00055562
What this trial is testing

Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma

Who this might be right for
MelanomaNeoplasm Metastasis
Celgene Corporation 274
Early research (Phase 1)Study completedNCT02654964
What this trial is testing

Cancer Stem Cell High-Throughput Drug Screening Study

Who this might be right for
Glioblastoma Multiforme
Swedish Medical Center 9
Testing effectiveness (Phase 2)Study completedNCT05103293
What this trial is testing

PTC Guiding Neoadjuvant Treatment in Breast Cancer

Who this might be right for
Pathological Conditions, Signs and Symptoms
Zhejiang Cancer Hospital 86
Not applicableWithdrawnNCT01769911
What this trial is testing

Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAIDS-related Diffuse Large Cell LymphomaAIDS-related Diffuse Mixed Cell Lymphoma+42 more
Fred Hutchinson Cancer Center
Not applicableEnded earlyNCT00470392
What this trial is testing

Mechanistically-based Optimization of UV Radiation Therapy in Psoriasis

Who this might be right for
Psoriasis
VA Office of Research and Development 9
Early research (Phase 1)Study completedNCT01684241
What this trial is testing

RBL001/RBL002 Phase I Clinical Trial

Who this might be right for
Melanoma
BioNTech RNA Pharmaceuticals GmbH 29
Large-scale testing (Phase 3)Active Not RecruitingNCT02176967
What this trial is testing

Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma

Who this might be right for
GanglioneuroblastomaLocalized Resectable NeuroblastomaLocalized Unresectable Neuroblastoma+1 more
Children's Oncology Group 621
Large-scale testing (Phase 3)Active Not RecruitingNCT04309409
What this trial is testing

Adjuvant Nivolumab Treatment in Stage II (IIA, IIB, IIC) High-risk Melanoma

Who this might be right for
Malignant Melanoma Stage II
University Hospital, Essen 374
Not applicableStudy completedNCT06369428
What this trial is testing

Patient Characteristics, Treatment Patterns, and Healthcare Resource Utilization of Metastatic Melanoma Patients

Who this might be right for
Metastatic Melanoma
Novartis 1,795
Not applicableLooking for participantsNCT06215495
What this trial is testing

A Novel Target Delineation Scheme in High-grade Glioma Patients: a Randomized Single-blind Clinical Trial

Who this might be right for
Radiation ToxicityMRI Simulated PositioningHigh Grade Glioma+2 more
Zhujiang Hospital 88
Early research (Phase 1)Study completedNCT00688090
What this trial is testing

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma.

Who this might be right for
Advanced MelanomaStage III and IV Melanoma
Mannkind Corporation 19
Very early researchUnknownNCT03113019
What this trial is testing

Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Breast Cancer

Who this might be right for
Breast Cancer
Research Institute of Fundamental and Clinical Immunology 26
Post-approval studies (Phase 4)UnknownNCT04447053
What this trial is testing

Sequential Belimumab and T-cell Based Therapy in SLE

Who this might be right for
Systemic Lupus Erythematosus
National University Hospital, Singapore 80
Not applicableStudy completedNCT02673905
What this trial is testing

Clinical Trial for the Regeneration of Cartilage Lesions in the Knee

Who this might be right for
Tear; Knee, Cartilage, Articular
University Hospital, Basel, Switzerland 108
Testing effectiveness (Phase 2)UnknownNCT03939741
What this trial is testing

SVF (Adipose Tissue Derived MSC) Based Therapy for CKD.

Who this might be right for
Chronic Kidney Diseases
Bangladesh Laser & Cell Surgery Institute & Hospital 31
Not applicableActive Not RecruitingNCT04056247
What this trial is testing

Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments

Who this might be right for
Stage IV Non-small Cell Lung CancerStage IV Malignant MelanomaStage IV Small Cell Lung Cancer+2 more
OncoHost Ltd. 10,000
Early research (Phase 1)Study completedNCT02051751
What this trial is testing

Evaluate the Potential Benefit of the Addition of BYL719 to Paclitaxel in the Treatment of Breast Cancer and Head-and-neck Cancer

Who this might be right for
Neoplasms, Breast Neoplasms, Head and Neck Neoplasms
Novartis Pharmaceuticals 19
Load More Results